Title: Beck A, et al. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017 May;16(5):315-337.
883731-65-5 | 3,3-Difluorocyclopentanol | AA00IEZW | MFCD22056289
885950-38-9 | Perfluorophenyl 4-(tert-butyl)benzenesulfonate | AA00IF5A | MFCD05975131
887581-54-6 | 6-tert-Butylindole | AA00IFCZ | MFCD07367958
89323-11-5 | 4-Amino-2-sulfanylpyrimidine-5-carboxamide | AA00IFJY | MFCD22192593
89854-96-6 | 3-(Methylamino)cyclohexanol | AA00IFRZ | MFCD16620320
9011-18-1 | Dextran, hydrogen sulfate, sodium salt | AA00IFY3 | MFCD00081551
906665-99-4 | [3,5-Bis(benzyloxy)phenyl]boronic acid | AA00IG6D | MFCD27935893
91152-30-6 | 1-(3-Chloropropyl)pyrrolidin-2-one | AA00IGFR | MFCD09742124
915230-14-7 | 4,4-Difluoro-l-proline methyl ester trifluoroacetate | AA00IGO2 | MFCD22415243
918810-70-5 | N-[3-(Aminomethyl)phenyl]cyclopropanecarboxamide | AA00IGUJ | MFCD08444256